...
首页> 外文期刊>Multiple Sclerosis Journal ?C Experimental, Translational and Clinical >Survival following the placement of gastrostomy tube in patients with multiple sclerosis
【24h】

Survival following the placement of gastrostomy tube in patients with multiple sclerosis

机译:在患有多发性硬化症的患者中放置胃造口管后存活

获取原文
           

摘要

Background Around a third of people with multiple sclerosis (MS) experience dysphagia. There is a need for disease-specific information on survival following placement of gastrostomy tube in people with MS. Objective We aimed to study survival following gastrostomy in patients with MS. Methods We reviewed medical records, home enteral feeding database and death certificates of people with MS who had gastrostomy from 2005 to 2017. Cox regression analysis was performed to identify independent predictors associated with mortality after gastrostomy. Results Median survival of 53 patients with MS after gastrostomy was 21.73 months. Median duration of hospital stay after gastrostomy was 14 days (IQR 5.25, 51.5). Survival at 30 days, 3 months, 1, 2, 5 and 10 years were 100% (53/53), 98.1% (52/53), 81.1% (43/53), 54.7% (29/53), 22.4% (11/49) and 6.8% (3/44), respectively. Of 53 patients, 24 died due to respiratory tract infection. Patients who had gastrostomy tube before 50 years of age survived longer (median 28.48 months) compared with those who had the gastrostomy after age 50 years (median 17.51 months) (p?=?0.040). Conclusion Around 54% of patients with MS survived two or more years following gastrostomy. Younger patients had better survival. The most frequent cause of death was respiratory infection.
机译:背景中三分之一的人患有多发性硬化症(MS)经历吞咽困难。在用MS的人的人们中放置胃造口管后,需要疾病特异性信息。目的我们旨在在MS患者胃造口术后研究存活。方法我们审查了医疗记录,家庭肠内喂养数据库和2005年胃术的人的死亡证明。进行了Cox回归分析,以确定胃术后死亡率相关的独立预测因子。结果胃痛术后53例MS患者的中位存活率为21.73个月。胃造口术后的医院住宿期间中位数为14天(IQR 5.25,51.5)。 30天内生存,3个月,1,2,5和10年为100%(53/53),98.1%(52/53),81.1%(43/53),54.7%(29/53),22.4 %(11/49)和6.8%(3/44)。 53例患者,24例由于呼吸道感染而死亡。与50岁以后胃术(中位数17.51个月)的胃术相比,患有胃术治疗的患者(中位数28.48个月)(中位数17.51个月)(p?= 0.040)。结论胃造口术后两年或多年来,MS患者的约54%左右。年轻患者生存更好。最常见的死因是呼吸道感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号